홈 › 암 (전체) › 미시간 › Grand Rapids
MI Grand Rapids의 암 (전체) 임상 시험
암 (전체) 관련 연구 28개가 Grand Rapids 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
피험자 모집 중2상
- START Midwest ( Site 1103), Grand Rapids
REC-7735 in Participants With Solid Tumors
피험자 모집 중1/2상
- START Midwest, Grand Rapids
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
피험자 모집 중1상
- START Midwest /ID# 279035, Grand Rapids
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
피험자 모집 중1/2상
- Corewell Health ( Site 4001), Grand Rapids
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
피험자 모집 중1상
- Start Midwest, Grand Rapids
A Study of JNJ-87890387 for Advanced Solid Tumors
피험자 모집 중1상
- Start Midwest, Grand Rapids
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
피험자 모집 중3상
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
피험자 모집 중2상
- Cancer Research Consortium of West Michigan, Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- START Midwest, Grand Rapids
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
피험자 모집 중1/2상
- Corewell Health ( Site 3001), Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- START - Midwest Cancer Research Center, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- The Cancer & Hematology Centers, Grand Rapids
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
피험자 모집 중3상
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
피험자 모집 중1상
- START Midwest, Grand Rapids
Project: Every Child for Younger Patients With Cancer
피험자 모집 중관찰 연구
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
피험자 모집 중1/2상
- Site 04, Grand Rapids
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
피험자 모집 중1상
- START Midwest, Grand Rapids
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
피험자 모집 중1상
- START Midwest, Grand Rapids
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
피험자 모집 중3상
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
피험자 모집 중1상건강한 지원자 환영
- BAMF Health Inc., Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- START Midwest, Grand Rapids
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
피험자 모집 중1/2상
- START Midwest, Grand Rapids
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
피험자 모집 중1상
- GSK Investigational Site, Grand Rapids
CT-95 in Advanced Cancers Associated With Mesothelin Expression
피험자 모집 중1상
- Context Investigational Site, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
피험자 모집 중1상
- START Midwest, Grand Rapids
A Study of YL242 in Subjects With Advanced Solid Tumors
피험자 모집 중1/2상
- US-206, Grand Rapids
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
피험자 모집 중관찰 연구
- Corewell Health, Grand Rapids
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
피험자 모집 중
- Mercy Health Saint Mary's, Grand Rapids
- Spectrum Health at Butterworth Campus, Grand Rapids
다른 도시의 암 (전체) 시험
- Houston, TX연구 121개
- New York City, NY연구 109개
- Boston, MA연구 85개
- Los Angeles, CA연구 74개
- Nashville, TN연구 65개
- Philadelphia, PA연구 59개
- Washington, DC연구 58개
- Durham, NC연구 58개
- Chicago, IL연구 51개
- Atlanta, GA연구 49개
- Seattle, WA연구 49개
- Arlington, VA연구 48개
Grand Rapids의 다른 연구
- 비소세포폐암연구 44개
- 대장직장암연구 40개
- 유방암연구 26개
- 난소암연구 24개
- 전이성 암연구 22개
- 전립선암연구 19개
- 자궁내막암연구 18개
- 위암연구 18개
- 췌장암연구 18개
- 흑색종연구 17개
- 두경부 편평세포암연구 15개
- 삼중음성 유방암연구 15개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.